Department of Medical Sciences, University of Edinburgh, Edinburgh, UK.
BMC Med. 2010 Sep 27;8:55. doi: 10.1186/1741-7015-8-55.
Although the assessment of cardiovascular risk in individual patients takes into account a range of risk factors, the diagnosis and management of hypertension (high blood pressure) is largely determined by a single numerical value, albeit that often several readings are taken over time. Given the critical impact of a decision to embark on lifelong drug therapy, the importance of ensuring that a blood pressure (BP) record is both accurate and representative is clear. However, there is good evidence that the variability of BP is such that even if measurement is of the highest quality, it can be difficult to say with confidence whether a patient is above or below a treatment threshold. This commentary argues that current BP measurement is inadequate to make the clinical decisions that are necessary and that multiple readings are required to deliver an acceptable degree of accuracy for safe decision-making. This is impractical in a doctor's surgery, and the only realistic long-term strategy is to involve the patient in measuring his or her own BP in their own environment. Evidence is presented that such a strategy is better able to predict risk, is cost-effective for diagnosing hypertension, can improve BP control and is thus better able to protect individuals in the future. In this commentary, I explain why doctors and other healthcare professionals should increase their familiarity with the technology, be aware of its strengths and limitations and work with patients as they become more empowered in the management of their chronic condition, hypertension.
虽然对个体患者的心血管风险评估会考虑一系列风险因素,但高血压(高血压)的诊断和治疗主要取决于一个单一的数值,尽管通常会在一段时间内进行多次测量。鉴于开始终身药物治疗的决定具有重大影响,确保血压(BP)记录既准确又有代表性显然非常重要。然而,有充分的证据表明,BP 的变异性很大,即使测量质量最高,也很难有把握地确定患者的血压是否高于或低于治疗阈值。本评论认为,目前的 BP 测量不足以做出必要的临床决策,需要多次测量才能达到安全决策所需的可接受准确度。在医生的手术中,这是不切实际的,唯一现实的长期策略是让患者在自己的环境中测量自己的 BP。有证据表明,这种策略能够更好地预测风险,在诊断高血压方面具有成本效益,可以改善血压控制,从而更好地保护未来的个人。在本评论中,我解释了为什么医生和其他医疗保健专业人员应该增加对该技术的熟悉程度,了解其优势和局限性,并在患者在管理其慢性疾病(高血压)方面获得更多权力时与他们合作。